Clinical Trial Update: Safety and Immunogenicity of IPOVAC in Young Children [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the safety and immunogenicity of IPOVAC in young children with poliomyelitis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• IPOVAC

Snippet

Sponsor: National Institute of Hygiene and Epidemiology, Vietnam | Conditions: Poliomyelitis | Phase 2 | Status: COMPLETED